Objectives/Hypothesis: To identify factors influencing the severity of epistaxis in hereditary hemorrhagic telangiectasia (HHT).
INTRODUCTION
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Rendu-Weber syndrome, 1 is an autosomaldominant disorder that leads to the development of abnormal vessels. The most common clinical feature is epistaxis (nosebleeds), which often occurs on a daily basis. 2 Other disease manifestations include gastrointestinal telangiectasia and arteriovenous malformations, particularly in the pulmonary, hepatic, and cerebral circulations. Careful epidemiologic studies reveal that HHT affects approximately 1 in 5,000 individuals. 3, 4 HHT is caused by mutations in the endoglin, ALK1/ACVRL1, or Smad4 genes. 5 The mutated genes encode proteins that mediate transforming growth factor-beta superfamily signaling in vascular endothelial cells. Disruption of signaling pathways in HHT pathogenicity results in remodeled vasculature, with dilation of venules and concomitant arteriovenous communications. 6, 7 The current perspective of pathogenesis is that HHT vessels result from aberrant responses to injuryinduced angiogenic stimuli, when the mutated genes in HHT appear to result in the inability of a blood vessel to mature appropriately. 1, [6] [7] [8] More than 90% of HHT patients experience spontaneous recurrent epistaxis secondary to telangiectasia of the nasal mucosa. 8 Both severity and frequency of HHTrelated epistaxis vary widely. 9 Frequency may range from a few bleeds yearly to several each day, and severity may range from a few drops to unmanageable flows with acute hemodynamic disturbances. Chronic iron-deficiency anemia and transfusion dependence are common. 1, 9 Increased frequency and duration of epistaxis in those with HHT are associated with a decreased quality of life.
Otorhinolaryngologic management of HHT epistaxis includes cauterization, laser photocoagulation, 12 septal dermoplasty, 13 and Young's procedure (nostril closure). Ligation and embolization treatments have also been used. 9 Medical treatments using both estrogen and antiestrogen therapy are now supported by small randomized, controlled trials. 14, 15 There is increasing interest in the use of antiangiogenesis therapies, such as bevacizumab (Avastin) 16, 17 and thalidomide. 6 Therapeutic manipulation of coagulation and fibrinolytic pathways [18] [19] [20] and antioxidant therapies 21 are also employed to try to limit blood loss in HHT. Many patients require more than one modality, with more invasive surgical treatments generally reserved for patients remaining transfusion dependent or severely symptomatic despite standard therapy. 22 Anecdotal reports from patients in our clinic suggested several lifestyle factors and conservative treatments that may have provocative or beneficial effects on nosebleeds in HHT. Only a proportion had been examined in prior formal publications. 9, 23 The goal of this study was to use a nonbiased patient survey to identify factors associated with changes in epistaxis severity in HHT.
MATERIALS AND METHODS

Study Design
To capture patient experiences of treatment and lifestyle factors affecting nosebleeds in an unbiased manner, we incorporated relevant questions into a wider ongoing survey regarding health and treatments for people with HHT and general population controls. The full study addressed general and HHT demographics, factors influencing HHT nosebleed severity, and prevalence and behavior of common medical conditions in the participant and relatives. The study received a favorable ethics opinion by NRES Committee East Midlands-Derby 1 Research Ethics Committee before online launch (www.imperial.ac.uk/ medicine/HHTsurvey2012).
For the current study, relevant data were downloaded on May 10, 2012. Participants were asked ''Have you had any of these […] treatments for HHT nosebleeds?'' and were then asked to score the effects of treatments as ''much better,'' ''a bit better,'' ''no different really,'' ''a bit worse,'' or ''much worse.'' Additional options of ''sometimes better-but not always'' and ''sometimes worse-but not always'' were provided for invasive treatments (cauterization, laser treatment, septal dermoplasty, Young's procedure [nostril closure], arterial ligation, and embolization). They had the opportunity to tick more than box per treatment if it didn't always have the same result for medical treatments. Participants were also asked to score the effects of specific lifestyle changes as ''much better,'' ''a bit better,'' ''no different really,'' ''a bit worse,'' or ''much worse.'' Finally, they were given the opportunity to provide information on any other medical treatment or lifestyle or dietary item that seemed to lead to a change in their nosebleeds and then were asked to detail whether that was a beneficial or detrimental change.
Patient Population
Potential participants were recruited through the Imperial College London HHTIC London Clinical Service databases (2001 to present) by post, during attendance at the HHT clinics, and by advertisement by the HHT Foundation International.
Answers from individuals who filled in paper-format questionnaires were transcribed into the online survey by the study team. Non-HHT participants were also recruited and provided comparison data for nosebleed frequency in the HHT and general populations.
Statistical Methods
Question responses ''much better,'' ''a bit better''/''better,'' ''no different,'' ''a bit worse''/''worse,'' ''much worse,'' ''sometimes better-but not always,'' and ''sometimes worse-but not always'' were converted into numeric format (þ2, þ1, 0, À1, À2, þ0.5, and À0.5, respectively) to generate ''response means.'' Interventions volunteered by participants were scored as þ1 (''better'') or À1 (''worse'') and summed to generate a ''score.'' ''Scores'' could not be compared to ''response means'' because of the absence of the formal ''no difference'' response category (occasional individuals volunteered a ''no difference'' effect using free text). GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA) was used to calculate descriptive statistics and to compare variables quantified in the same manner using the Fisher exact test (proportions) or Mann Whitney U test (two variables).
RESULTS
Population Characteristics
In total, 771 responses were received at the time of data download from 666 individuals with HHT and 105 controls. The average age of HHT and non-HHT participants was 54 years (range, 21-87) and 53 years (range, 21-86), respectively. Females accounted for 436 of 663 (66%) HHT participants and 70 of 105 (67%) non-HHT participants. The majority of participants were Caucasian and were living in the United States, United Kingdom, Europe, Canada, or Australia. The proportion of HHT participants reporting epistaxis (649/666, 97%) was significantly higher than the proportion of non-HHT patients (70/105, 67%), P < .0001. The frequency of nosebleeds experienced by the HHT participants was also higher (Fig. 1A) .
Treatment Modalities in HHT-Related Epistaxis
A total of 326 participants reported the use of specialist invasive treatments for HHT epistaxis (Fig. 1B) . Of the 170 requiring emergency packing, 164 (96%) had used either (or more commonly both) cauterization or laser therapy. More invasive treatments were almost always used in patients who had also received cauterization and/or laser therapy.
Approximately half of those treated by cauterization (138/267, 52%) or laser photocoagulation (109/221, 49%), and smaller proportions receiving other modalities, provided a response report (Fig. 2) . The graded responses to each specified treatment (spanning beneficial, no difference, and detrimental options) were scored to generate a response mean. Of those patients reporting an effect, most reported a benefit, and all invasive treatment modalities demonstrated positive responses. For the two major outpatient procedures, laser therapy was more frequently reported as beneficial than cauterization (Mann Whitney U, P < .0001).
Medical treatments for HHT epistaxis fell into two categories (Fig. 3) . Female hormones (which could have been used for any indication including oral contraception and hormone replacement) and antiestrogens (tamoxifen/raloxifene) were specified in the questionnaire; the graded responses (spanning beneficial, no difference, and detrimental options) were scored to generate a response mean. High proportions of individuals receiving these agents provided a response report: 275 of 330 (83%) of those receiving female hormones and 30 of 33 (91%) receiving tamoxifen/raloxifene. Both were generally reported as beneficial, although the response mean for tamoxifen/raloxifene was significantly higher than that for female hormones (Mann Whitney U, P ¼ .0037). The other four groups volunteered by study participants (aminocaproic acid, bevacizumab, nasal antibiotic ointments, and tranexamic acid) were also more frequently reported as having a beneficial effect on epistaxis.
For these volunteered agents, participant responses (beneficial or detrimental) were summed to generate positive (beneficial) ''scores.''
Other Medical and Lifestyle Influences
Other agents used by HHT patients also fell into questionnaire-specified and participant-volunteered categories (Fig. 4) . Steroid hormones (excluding topical agents or inhalers) and iron tablets were specified in the questionnaire: each was as commonly reported with beneficial as detrimental effects. The other agents were volunteered by study participants. Nasal humidification regimens were all reported as having beneficial effects on nosebleeds (95% confidence intervals [95% CI] for scores greater than zero). Surprisingly, the Chinese herb Yunnan Baiyao was frequently reported as being beneficial (score, 1.5 [95% CI, 1.06-1.94]), as were nasal The effects of specific lifestyle variables requested (different foods/drinks, season/temperature, mood/stress/ anxiety, lifestyle activities/sports, and nasal knock/ injury) were all reported as detrimental (Fig. 5) . When participants volunteered details (Fig. 5) , the majority of reports (all negative) cited extremes and changes in temperature (n ¼ 133), low humidity (n ¼ 80), both temperature and low humidity (n ¼ 23), or springtime allergies (n ¼ 31). For activities and sports, reports were generally negative, although two participants reported beneficial effects from aerobic sports.
The most unexpected data were the 25 different food items reported (Fig. 6 ): all except soy were reported only as having detrimental effects on epistaxis. The most frequently reported items were alcohol (n ¼ 45, 6.8% of participants) and spices (n ¼ 26, 3.9% of participants). We noted that most of the foods reported to exacerbate epistaxis were high in salicylates (including spices, chocolate, coffee, and certain fruits), [24] [25] [26] other natural compounds reported to have antiplatelet activities (red wine, garlic, ginger, ginseng, ginkgo biloba, and vitamin E), [27] [28] [29] [30] or in omega-3 acids (oily fish, salmon). 31 
DISCUSSION
Management of HHT epistaxis is difficult, and because it is a rare disease, individual practitioners rarely treat large number of patients outside of HHT centers. In this study using a nonbiased questionnaire and international HHT patients, we highlight the need for multiple different treatment modalities, which were generally reported as beneficial. More importantly, the data provide potential options for lifestyle modifications.
The strengths of the study were the use of a nonbiased questionnaire amenable to quantification. Limitations were that only a proportion of participants reported the effect of specific variables on their epistaxis: 83% to 91% for estrogen and antiestrogen therapies, approximately 50% for laser and cauterization, low for more invasive modalities, and not ascertainable for other treatments and lifestyle factors. The intention of dedicated treatments was known to the patients, and the reported beneficial responses may therefore have included placebo responses. However, the goal of the study was not to evaluate the beneficial effects of specific treatments but to identify other factors modifying nosebleed severity. Overall, the findings of treatment scores). Note that the total number of respondents using nasal antibiotics, aminocaproic acid, tranexamic acid, and bevacizumab were not captured, as these treatment effects were volunteered by the participants. The likely absence of individuals for whom effects on epistaxis would have been reported as ''no difference'' means that these scores cannot be compared to the response means for estrogens or antiestrogens. benefits strengthened our confidence in the subsequent reports associated with environmental and lifestyle factors: Salicylate content and antiplatelet activities of dietary food items are not generally appreciated, and we suspect, but cannot prove, that this was not known to the participants reporting effects on their nosebleeds. The use of a subjective questionnaire-based study meant that the effects attributable to one particular treatment or variable could not be isolated from potentially independent and/or interactive effects of other therapeutic, lifestyle, pathogenic, or genetic variables. The responses were not reported consistently by all patients, and the reasons for this variability are not yet understood.
That said, the data do add to the limited published literature. Use of specific otorhinolaryngologic treatments in HHT is guided by expert opinion and the findings of case series. For example, recent international guidance recommended the use of laser therapy over cauterization. 9 Our study findings provide direct evidence to suggest that the use of laser treatment may be preferable to cauterization in HHT. Medical therapies, particularly hormonal therapies that are supported by randomized control trials in HHT, 14, 15 were also reported as beneficial. To date no formal comparisons have been made between estrogens and antiestrogens in the treatment of HHT-related epistaxis. The current study begins to suggest that the use of antiestrogen treatment may be favorable to hormone treatment, although the lower hormonal score may in part reflect the variety of estrogen/progesterone dosing regimens used by participants. Beneficial effects were also reported for aminocaproic acid, tranexamic acid, antibiotic ointments, and bevacizumab. No data were volunteered by participants for thalidomide or antioxidants. Trauma to the nose and high anxiety levels were reported to worsen nosebleeds, along with almost all patient-reported variables relating to environmental factors. These findings support both wide anecdotal consensus and the findings of a single questionnaire-based study (n ¼ 49), 23 which reported changes in temperature, low humidity, sneezing, bending over, strenuous activity, and alcohol as aggravating factors for nosebleeds in HHT. These factors are likely to influence epistaxis through drying of the nasal mucosa by fluctuations in temperature and humidity, external trauma to telangiectasia, and increased perfusion pressure of the vessels whilst bending over. Many of these factors also lead to epistaxis in the general population, 32 owing to the superficial and easily traumatized multidirectional arterial anastomotic system of the nose. 33 We believe the most important data from this study relate to potential forms of self-management in this chronic condition. Consensus opinion has suggested the use of humidification and regular lubrication of the nostrils, 9 based on anecdotal reports and the likelihood that crusting and drying of the nasal mucosa will exacerbate damage of the nasal telangiectasia, precipitating hemorrhage. 8, 9 For example, saline irrigation of the nostrils has been postulated as a useful method of preventing deeper crusting when tolerated by the patient. 34 In our study, the positive (beneficial) scores for room humidification (1.50 Eight participants reported using Yunnan Baiyao, a traditional Chinese herbal medicine widely used in the treatment of hemorrhages and wounds and shown in several randomized, controlled trials to reduce intraoperative bleeding due to its hemostatic properties. [35] [36] [37] [38] Similarly, two participants reported beneficial effects from soy, which reduced bleeding from mechanically injured vessels in thrombocytopenic dogs 39 and was associated with decreased risk of subarachnoid hemorrhage in a Japanese population. 40 For these agents, further study of efficacy, tolerability, and mechanisms that may be involved in alleviating HHT epistaxis is indicated in a wider group of patients. As for other potentially prothrombotic agents, examination of sideeffect profiles is important, particularly with the recent demonstration of the heightened risk of venous thromboemboli in iron-deficient HHT patients. 41 Nosebleeds are more frequent and prolonged for individuals in the general population using antiplatelet 42 and anticoagulant therapies, 40 and the current study suggests this may be the case for HHT patients. There were also deleterious reports for food items reported to have similar activities.
The two most commonly reported groups of agents to exacerbate HHT epistaxis were alcohol (especially red wine) and spices. Total salicylates and salicylic acid are high in a wide variety of spices, [24] [25] [26] with antiplatelet activity of curcumin, a food spice from turmeric, reported by numerous groups. [43] [44] [45] Curcumin is also recognized to inhibit vascular smooth muscle cell functions relevant to responses to vascular injury, 46 the process currently considered to precipitate HHT hemorrhage. There is already substantial literature regarding the mechanisms by which red wine appears to have a beneficial effect protecting against cardiovascular disease in the apparent ''French paradox.'' 47 We can also speculate that the detrimental effects of alcohol in the current study may be attributable not only to vasodilatation but also to the reported association between alcohol and reduced platelet aggregation. 48 Chocolate was the next most commonly reported item to exacerbate HHT epistaxis (Fig. 6) . Multiple studies have emphasized different antiplatelet effects of cocoa, [49] [50] its flavonol constituents, 51, 52 and specifically dark chocolate. [53] [54] [55] [56] Similarly, antiplatelet activity for omega-3 is recognized, [57] [58] [59] with reduced microvascular thromboses demonstrated in a porcine model, 60 although it is not clear whether this usually translates to clinically relevant hemorrhagic risk. 61, 62 In the current study, items containing fish oil and omega-3 were reported as worsening epistaxis by 15 HHT patients. In addition, most fruits, especially berry fruits and dried fruits, many vegetables, tea, and honey contain salicylate, [24] [25] [26] although functional evidence of antiplatelet activities has generally not been reported to date. Antiplatelet activity is also recognized for a wide variety of additional food and dietary items: Pribitkin et al. 28 and Ciocon et al. 29 emphasized the importance of garlic, ginger, ginseng, and Ginkgo biloba (the 4 Gs), and in the current study each was reported by multiple different HHT participants as exacerbating their nosebleeds (Fig. 6) .
CONCLUSION
This study suggests that HHT patients with troublesome epistaxis may be advised to try simple risk-free strategies including avoidance or monitored intake of high-salicylate foods and other dietary items reported as deleterious in this study. Acute aggravation of HHT epistaxis could serve as an activity biomarker for proposed dietary maneuvers to protect against atherosclerosis and vascular diseases. 
